PCOS Rebranded as PMOS: Experts Debate Whether New Name Improves Clinical Care
Summary
JAMA Medical News Podcast discusses the rebranding of PCOS (polycystic ovary syndrome) to PMOS (polyendocrine metabolic ovarian syndrome). The change reflects that the old name no longer accurately represents what is known about the condition, which involves broader endocrine and metabolic issues beyond just ovarian cysts. The podcast features JAMA's News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer exploring whether the new name will translate to improved clinical care.
Source
Twitter / XPCOS Rebranded as PMOS: Experts Debate Whether New Name Improves Clinical Careja.maKey quotes
· 2 pulledPCOS is now called PMOS, or polyendocrine metabolic ovarian syndrome.
The short answer to your question is that many experts and patients believe the old name no longer reflects what we know about the condition.
You might also wanna read
PCOS Renamed to PMOS: A Step Forward for Women's Health Recognition
A registered dietitian and women's health advocate celebrates the renaming of Polycystic Ovarian Syndrome (PCOS) to Polyendocrine Metabolic
inspirethemind.org·24d ago
Doctors adopt new term 'hormone therapy' to reflect updated approach to menopause symptom management
Health care providers are shifting terminology from "hormone replacement therapy" to "hormone therapy" when treating menopause symptoms. Thi
1011now.com·21d ago
Ovarian aging as a systemic regulator of female healthspan: A call for paradigm shift in geroscience
This Perspective article argues that the ovary should be recognized not merely as a reproductive organ but as a systemic regulator of female
plos.io·1mo ago
Research Suggests Heart Disease, Kidney Disease and Type 2 Diabetes May Be One Condition Treatable with GLP-1 Drugs
The article discusses the emerging medical concept of "CKM syndrome" (cardiometabolic kidney syndrome), which suggests that heart disease, k
scientificamerican.com·6mo agoBest diet to prevent weight gain during menopause | Medical News Bulletin
Comments
Sign in to join the conversation.
No comments yet. Be the first.